View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Ofatumumab 1000 / Bendamustine 90, Chronic Lymphocytic Leukemia, cycle 2+
Protocol-ID: 432 V1.0 (Mini), OFAT1000/BEND90, CLL C2+Indication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
Links
- Ofatumumab and Bendamustine Combination Therapy in Patients With Untreated and Relapsed Chronic Lymphocytic Leukemia: Initial Results of the Phase II Study OMB115991 [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 15.02.2015